Citigroup’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.37M Sell
29,674
-16
-0.1% -$1.82K ﹤0.01% 1692
2025
Q1
$3.12M Buy
29,690
+1,702
+6% +$179K ﹤0.01% 1759
2024
Q4
$3M Buy
27,988
+2,408
+9% +$258K ﹤0.01% 1828
2024
Q3
$2.56M Buy
25,580
+11,107
+77% +$1.11M ﹤0.01% 1854
2024
Q2
$1.22M Buy
14,473
+1,211
+9% +$102K ﹤0.01% 2120
2024
Q1
$969K Buy
13,262
+816
+7% +$59.7K ﹤0.01% 2386
2023
Q4
$889K Buy
12,446
+3,669
+42% +$262K ﹤0.01% 2248
2023
Q3
$526K Sell
8,777
-7,295
-45% -$437K ﹤0.01% 2372
2023
Q2
$1.16M Buy
16,072
+3,676
+30% +$265K ﹤0.01% 2134
2023
Q1
$912K Sell
12,396
-572
-4% -$42.1K ﹤0.01% 2083
2022
Q4
$866K Sell
12,968
-54,938
-81% -$3.67M ﹤0.01% 2139
2022
Q3
$3.65M Buy
67,906
+9,174
+16% +$493K ﹤0.01% 1255
2022
Q2
$3.27M Buy
58,732
+20,359
+53% +$1.13M ﹤0.01% 1301
2022
Q1
$2.69M Sell
38,373
-29,171
-43% -$2.05M ﹤0.01% 1550
2021
Q4
$6.51M Buy
67,544
+10,267
+18% +$989K ﹤0.01% 1137
2021
Q3
$4.98M Buy
57,277
+893
+2% +$77.6K ﹤0.01% 1317
2021
Q2
$4.62M Buy
56,384
+10,064
+22% +$824K ﹤0.01% 1479
2021
Q1
$4.41M Buy
46,320
+37,536
+427% +$3.57M ﹤0.01% 1411
2020
Q4
$545K Buy
8,784
+5,168
+143% +$321K ﹤0.01% 2577
2020
Q3
$215K Sell
3,616
-23,548
-87% -$1.4M ﹤0.01% 2743
2020
Q2
$1.9M Sell
27,164
-13,656
-33% -$953K ﹤0.01% 1655
2020
Q1
$1.85M Buy
40,820
+15,962
+64% +$724K ﹤0.01% 1427
2019
Q4
$1.62M Sell
24,858
-832
-3% -$54.1K ﹤0.01% 1847
2019
Q3
$1.6M Buy
25,690
+2,490
+11% +$155K ﹤0.01% 1780
2019
Q2
$1.65M Sell
23,200
-9,041
-28% -$644K ﹤0.01% 1782
2019
Q1
$2.53M Sell
32,241
-66,768
-67% -$5.24M ﹤0.01% 1355
2018
Q4
$8.38M Buy
99,009
+57,022
+136% +$4.83M 0.01% 771
2018
Q3
$7.19M Buy
41,987
+30,473
+265% +$5.22M 0.01% 830
2018
Q2
$1.49M Sell
11,514
-31,531
-73% -$4.07M ﹤0.01% 1638
2018
Q1
$4.44M Sell
43,045
-15,219
-26% -$1.57M ﹤0.01% 1033
2017
Q4
$4.98M Buy
58,264
+8,311
+17% +$710K ﹤0.01% 971
2017
Q3
$4.24M Sell
49,953
-1,784
-3% -$152K ﹤0.01% 1050
2017
Q2
$3.92M Buy
51,737
+4,035
+8% +$306K ﹤0.01% 1075
2017
Q1
$3.15M Sell
47,702
-88,090
-65% -$5.82M ﹤0.01% 1136
2016
Q4
$8.61M Buy
135,792
+111,157
+451% +$7.05M 0.01% 713
2016
Q3
$1.57M Buy
24,635
+14,972
+155% +$953K ﹤0.01% 1569
2016
Q2
$719K Sell
9,663
-11,208
-54% -$834K ﹤0.01% 1907
2016
Q1
$1.39M Sell
20,871
-41,793
-67% -$2.79M ﹤0.01% 1761
2015
Q4
$4.24M Buy
62,664
+2,712
+5% +$183K ﹤0.01% 961
2015
Q3
$3.2M Buy
59,952
+57,839
+2,737% +$3.09M ﹤0.01% 1081
2015
Q2
$133K Sell
2,113
-710
-25% -$44.7K ﹤0.01% 3056
2015
Q1
$136K Sell
2,823
-17,683
-86% -$852K ﹤0.01% 3204
2014
Q4
$681K Buy
20,506
+4,551
+29% +$151K ﹤0.01% 2155
2014
Q3
$468K Buy
15,955
+14,506
+1,001% +$425K ﹤0.01% 2068
2014
Q2
$56K Sell
1,449
-460
-24% -$17.8K ﹤0.01% 3480
2014
Q1
$80K Sell
1,909
-8,889
-82% -$373K ﹤0.01% 3672
2013
Q4
$355K Buy
10,798
+4,307
+66% +$142K ﹤0.01% 2651
2013
Q3
$175K Buy
6,491
+6,201
+2,138% +$167K ﹤0.01% 2700
2013
Q2
$7K Buy
+290
New +$7K ﹤0.01% 4587